AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Saluda Medical Inc.

1.195

+0.0655.75%

Volume:141.19K

Turnover:168.04K

Market Cap:301.17M

PE:-0.88

High:1.205

Open:1.160

Low:1.160

Close:1.130

52wk High:1.900

52wk Low:1.055

Shares:252.02M

Float Shares:252.02M

Volume Ratio:1.17

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.360

EPS(LYR):-0.892

ROE:-127.42%

ROA:-57.64%

PB:-0.43

PE(LYR):-1.34

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BRIEF-Saluda Medical Says FY26 Revenue Guidance Increased To $85 Million

Saluda Medical Inc - FY26 Revenue Guidance Increased to US$85 Mln

THOMSON REUTERS

Saluda Medical Receives Regulatory Approval for Eva™ Sensing Technology in Europe With Recognition in Australia

THOMSON REUTERS

Saluda Medical Secures European Regulator Approval for EVA Sensing Technology Product

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SLD.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SLD.AU\",,,,,undefined,":{"symbol":"SLD.AU","market":"AU","secType":"STK","nameCN":"Saluda Medical Inc.","latestPrice":1.195,"timestamp":1770613920000,"preClose":1.13,"halted":0,"volume":141194,"delay":0,"changeRate":0.05752212389380546,"nameEN":"Saluda Medical Inc.","floatShares":252023810,"shares":252023810,"eps":-1.359913,"marketStatus":"Not Yet Opened","change":0.065,"latestTime":"02-09 16:12:00 AEDT","open":1.16,"high":1.205,"low":1.16,"amount":168041,"amplitude":0.039823,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.359913,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":0,"adr":0,"listingDate":1764766800000,"exchange":"ASX","adjPreClose":1.13,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":1.1737488063007724,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SLD.AU\",,,,,undefined,":{"symbol":"SLD.AU","floatShares":252023810,"roa":"-57.64%","roe":"-127.42%","lyrEps":-0.891571,"volumeRatio":1.1737488063007724,"shares":252023810,"dividePrice":0,"high":1.205,"amplitude":0.039823,"preClose":1.13,"low":1.16,"week52Low":1.055,"pbRate":"-0.43","psRate":"3.04","week52High":1.9,"institutionHeld":0,"latestPrice":1.195,"eps":-1.359913,"divideRate":0,"volume":141194,"delay":0,"ttmEps":-1.359913,"open":1.16,"prevYearClose":1.425,"prevWeekClose":1.13,"prevMonthClose":1.235,"prevQuarterClose":1.425,"fiveDayClose":1.255,"twentyDayClose":1.185,"sixtyDayClose":2.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SLD.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606490757","title":"BRIEF-Saluda Medical Says FY26 Revenue Guidance Increased To $85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2606490757","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606490757?lang=en_us&edition=fundamental","pubTime":"2026-01-28 09:33","pubTimestamp":1769564032,"startTime":"0","endTime":"0","summary":"BRIEF-Saluda Medical Says FY26 Revenue Guidance Increased To $85 MillionJan 28 (Reuters) - Saluda Medical Inc SLD.AX:FY26 REVENUE GUIDANCE INCREASED TO US$85 MILLIONFurther company coverage: SLD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YS0GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLD.AU","BK7007"],"gpt_icon":0},{"id":"2606580117","title":"Saluda Medical Inc - FY26 Revenue Guidance Increased to US$85 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2606580117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606580117?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:21","pubTimestamp":1769548912,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS0GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","SLD.AU"],"gpt_icon":0},{"id":"2601350836","title":"Saluda Medical Receives Regulatory Approval for Eva™ Sensing Technology in Europe With Recognition in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2601350836","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601350836?lang=en_us&edition=fundamental","pubTime":"2026-01-08 18:00","pubTimestamp":1767866400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA1XH1S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLD.AU","BK7007"],"gpt_icon":0},{"id":"2593710150","title":"Saluda Medical Secures European Regulator Approval for EVA Sensing Technology Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2593710150","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593710150?lang=en_us&edition=fundamental","pubTime":"2025-12-22 14:50","pubTimestamp":1766386246,"startTime":"0","endTime":"0","summary":"Saluda Medical  said its next-generation EVA Sensing Technology product has now received CE certification for commercialization in Europe, with recognition of this approval in Australia, according to a Monday Australian bourse filing.This follows the US Food and Drug Administration approval of EVA in December 2024, the filing added.The company said its EVA Sensing Technology automates manual programming steps and objectively scans and analyzes a patient's spinal cord to deliver therapy with optimized precision.\"This approval is in line with our expectations and builds on the successful commercialisation we've seen in the US, this expansion allows us to bring a proven technology enhancement to more markets,\" said Chief Executive Barry Regan.The company added that a limited commercial release in Europe and Australia will begin in the first calendar quarter of 2026, followed by a full commercial release later in the year, and the timing of this approval and launch is in line with the comp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4156","EVA","BK7007","SLD.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SLD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}